Vantavo (previously Alendronate sodium and colecalciferol, MSD) ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

vantavo (previously alendronate sodium and colecalciferol, msd)

n.v. organon - alendronsyre, colecalciferol - osteoporose, postmenopausale - legemidler til behandling av bein sykdommer - behandling av postmenopausal osteoporose hos pasienter med risiko for vitamin d-mangel. vantavo reduserer risikoen for vertebrale og hoftebrudd. behandling av postmenopausal osteoporose hos pasienter som ikke får vitamin d-tilskudd og det er risiko for vitamin-d insuffisiens. vantavo reduserer risikoen for vertebrale og hoftebrudd.

Feiba 50 E/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

feiba 50 e/ ml

baxalta innovations gmbh - faktor viii hemmer bypassaktivitet - pulver og væske til infusjonsvæske, oppløsning - 50 e/ ml

Methotrexate Pfizer 25 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

methotrexate pfizer 25 mg/ ml

pfizer as - metotreksat - injeksjons-/infusjonsvæske, oppløsning - 25 mg/ ml

Acitretin Orifarm 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

acitretin orifarm 25 mg

orifarm generics a/s - acitretin - kapsel, hard - 25 mg

Acitretin Orifarm 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

acitretin orifarm 10 mg

orifarm generics a/s - acitretin - kapsel, hard - 10 mg

Salazopyrin EN 500 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

salazopyrin en 500 mg

pfizer as - sulfasalazin - enterotablett - 500 mg

Xeomin 100 E নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xeomin 100 e

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 100 e

Xeomin 50 E নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xeomin 50 e

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 50 e

Xeomin 200 E নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xeomin 200 e

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 200 e

Evkeeza ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

evkeeza

ultragenyx germany gmbh - evinacumab - hyperkolesterolemi - lipid modifiserende midler - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).